NCT03273088View on ClinicalTrials.gov

Pharmacokinetic, Safety and Tolerability Study of Altebrel in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

December 4, 2016

Primary Completion Date

March 15, 2017

Study Completion Date

March 15, 2017

Conditions
Phase 1Bioequivalence
Interventions
DRUG

Etanercept

A single dose of etanercept (25mg/0.5ml prefilled syringe) was administered subcutaneously to healthy subjects.

Trial Locations (1)

Unknown

Orchidpharmed PK/PD site, Tehrān

Sponsors
All Listed Sponsors
lead

AryoGen Pharmed Co.

INDUSTRY